Cydan Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $34M
Latest Deal Amount
  • Investors
  • 6

Cydan General Information

Description

Operator of an orphan drug accelerator dedicated to creating therapies that improve the lives of patients living with rare genetic diseases. The company accelerates therapies through clinical, regulatory and commercial development for treating patients with rare diseases, with approved treatments, enabling patients and families with rare diseases to be treated in a salutary way and help them recover soon.

Contact Information

Website
www.cydanco.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • 700 Technology Square
  • 3rd Floor
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cydan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 17-Oct-2017 $34M 0000 Completed Generating Revenue
1. Early Stage VC 01-Oct-2013 0000 0000 Completed Startup
To view Cydan’s complete valuation and funding history, request access »

Cydan Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an orphan drug accelerator dedicated to creating therapies that improve the lives of patients living with ra
Drug Discovery
Cambridge, MA
7 As of 2021
0000
0000000000 0 0000

00000 00

t labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
0000 000000000
Austin, TX
00 As of 0000
0000
000000 - 000 0000

0000 000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
0000 000000000
San Diego, CA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cydan Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lumos Pharma Formerly VC-backed Austin, TX 00 0000 000000 - 000 0000
0000 000000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
00000 000000000000 Venture Capital-Backed Waltham, MA 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000&0 00000
000000000000 Venture Capital-Backed Clarksville, MD 0 00.000 000000 0
You’re viewing 5 of 29 competitors. Get the full list »

Cydan Executive Team (10)

Name Title Board Seat Contact Info
Christoph Adams Ph.D Co-Founder, Chief Executive Officer & Board Member
Imran Babar Ph.D Chief Business Officer
Niels Svenstrup Ph.D Senior Vice President, Development
Dione Kobayashi Ph.D Vice President of Preclinical Translation
ShiYin Foo MD Chief Medical Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Cydan Board Members (12)

Name Representing Role Since
Barbara Dalton Ph.D Pfizer Ventures Board Member 000 0000
Carl Goldfischer MD Bay City Capital Board Member 000 0000
Christoph Adams Ph.D Cydan Co-Founder, Chief Executive Officer & Board Member 000 0000
Joel Marcus JD Alexandria Venture Investments Board Observer 000 0000
Matthew McAviney MD New Enterprise Associates Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Cydan Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cydan Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Longitude Capital Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Bay City Capital Venture Capital Minority 000 0000 000000 0
Lundbeckfond Ventures Corporate Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Cydan Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 03-Jan-2019 00000 00000 00 0000 Biotechnology 000000000 00000 00.0
00000000 000 13-Jul-2016 000000000000000000 000 Pharmaceuticals
0000 0000000000 24-Jun-2015 000000000000000000 000 Other Healthcare Technology Systems 000000000 00000 00.0
Vtesse Accelerator/Incubator Drug Discovery
To view Cydan’s complete investments history, request access »

Cydan Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 000000000000000000 Completed
  • 00000
To view Cydan’s complete exits history, request access »